DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

NPPA sets retail prices for 41 drug combinations, including 18 variants of off-patent diabetes drug empagliflozin, following steep price drops post-patent expiry ...

King & Spalding still has about 175 products liability lawyers worldwide and another 130 specializing in toxic and ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

New outcomes from Boehringer Ingelheim Canada's Access for Health Education and Disease Management (AHEAD) program underscores the essential role that allied health professionals and disease ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on 24-25 November for in‑depth case studies, practical workshops and ...

LONDON, May 20 (Reuters) - Bank of England Chief Economist Huw Pill said the BoE's pace of interest rate cuts had been too fast given still strong wage pressures on inflation, but his vote this ...

Boehringer In­gel­heim claimed two Phase 3 wins for its PDE4 in­hibitor in fi­brot­ic lung dis­eases, but some Wall Street an­a­lysts said the can­di­date’s “mod­est” ef­fi­ca ...